← Leaderboards
Janice A Dominov
Massachusetts General Hospital
$2,167,669
Attributed
$2,167,669
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $388.3K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,167,669 · 3
By mechanism
R01$1,874,740 · 1
R21$210,200 · 1
R03$82,729 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jeffrey Boone Miller$10,193,153
- Jonathan L Tilly$11,512,275
- Jeevendra Martyn$10,698,401
- Michael J Whalen$16,701,509
- David E Kling$104,060
Others in their field
Top investigators on “Cell Proliferation”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- David Heimbrook · Leidos Biomedical Research, Inc.$103,164,048
- Timothy J Eberlein · Washington University$49,931,668
- Deirdre R. Meldrum · University Of Washington$37,202,510
- Robert A Weinberg · Whitehead Institute For Biomedical Res$32,735,166
Research focus
Cell ProliferationMuscle CellsApoptosisDefectAffectCongenital Muscular DystrophyCell SurvivalAge-MonthsActivation AnalysisCellsBax ProteinAnimalsBirthCessation Of LifeBirc4 GeneApoptoticApoptotic Protease-Activating Factor 1CaspaseCd8-Positive T-LymphocytesBasement MembraneAge Of OnsetCell DeathAccountingCritical Pathways
Grant awards (10)
Apoptosis in Laminin alpha2-Deficient Muscle Pathology$373,490
R01 · FY2009 · AR · contact PI
Apoptosis in Laminin alpha2-Deficient Muscle Pathology$358,771
R01 · FY2008 · AR · contact PI
Apoptosis in Laminin alpha2-Deficient Muscle Pathology$5,089
R01 · FY2008 · AR · contact PI
Apoptosis in Laminin alpha2-Deficient Muscle Pathology$366,093
R01 · FY2007 · AR · contact PI
Apoptosis in Laminin alpha2-Deficient Muscle Pathology$5,970
R01 · FY2007 · AR · contact PI
Apoptosis in Laminin alpha2-Deficient Muscle Pathology$377,027
R01 · FY2006 · AR · contact PI
Apoptosis in Laminin alpha2-Deficient Muscle Pathology$388,300
R01 · FY2005 · AR
Enhancement of Myoblast Chemotactic Migration$105,100
R21 · FY2003 · AR
Enhancement of Myoblast Chemotactic Migration$105,100
R21 · FY2002 · AR
THE ROLE OF BCL-2 IN SKELETAL MUSCLE STEM CELLS$82,729
R03 · FY2000 · AR